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Background
Pacemaker/ AICD imaging is currently clincally per-
formed in the MRI environment. A vigilant team con-
sisting of Cardiologist, EP staff, and technologists with
close patient monitoring and supervision has evolved
this heretofore risky endeavor into a procedure with
established safety if done properly. However, once safety
is established, does such add valuable irrefutable infor-
mation to merit that risk?
Hypothesis
We propose that MRI in patients with a PM/AICD is
crucial to confirm existing diagnosis while in many
instances modifies inital diagnosis and subsequent
patient management.
Methods
A total of 100 pts were imaged on a GE CV/i Excite 12,
1.5 T (GE, WI): 17 AICD, 10 PM/AICD, 5 single PM
lead (1 retained SVC AICD lead fragment), 8 REVO PM
and 62 PM. A specific criteria was followed for all the
pts undergoing this procedure to determine if final diag-
nosis provided additional information in pt care.
A checklist of 3 questions were gathered and answered
folowing final interpretation of the MRI.
1) Does diagnosis change?
2) Does MRI provide additional information to the
existing diagnosis?
3) Does patient management change?
If ‘yes’ was answered to any of the above questions it
was considered that MRI scan was of value to final
diagnosis.
Results
All pts completed MRI with no adverse events. The PM
was interrogated pre/post MRI by EP Lab and repro-
grammed under the direction of the Cardiologist. Aver-
age scan was 20±55min. Considering the 100 pts
imaged: 71 (70%) were neurology cases, 5 muscoskeleton
(5%) and 24(23%) were cardiac/vascular cases.
After reviewing the results from the 73 neurology
cases and comparing to prior studies (CT, angio, EEG
and/or myelogram), 17/71 (24%) showed the MRI not
only provided additional information but changed the
original diagnosis and in turn their course medical treat-
ment. 37 (53%) provided additional information to the
diagnosis. Thus, 54 pts (76%) demonstrated the MRI
was of value to the final diagnosis. 17/73 (24%) pts
imaged provided no further information but confirmed
original diagnosis. Of 5 muscoskeletal 4(80%) provided
additional information and 1(20%) changed manage-
ment. The 24 cardiac cases were compared to prior
studies (Cath, TEE, TTE and stress) and in 5 (21%) the
MRI provided additional information to change the ori-
ginal diagnosis and subsequent management. Finally,
18 (75%) provided extra information while 1(4%) con-
firmed the original diagnosis. In essence, 96% of the car-
diac population benefited by having an MRI.
Conclusions
The use of PM/AICD imaging in MRI remains contro-
versial but with a cautious cardiac team increased confi-
dence in its use is found. Herein, we show that MRI
procedures on carefully selected patients with pace-
makers/AICD’s are beneficial and substantially add valu-
able irrefutable information to patient diagnosis and
management. We propose that not only are Pacemakers/
AICD’s no longer forbidden in the MRI environment but
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